Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals
暂无分享,去创建一个
Libin Rong | Sunpeng Wang | Patricia Hottz | Mauro Schechter | L. Rong | M. Schechter | Sunpeng Wang | Patricia Hottz
[1] Richard A. Lempicki,et al. Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV , 2001, The Journal of experimental medicine.
[2] Alan S. Perelson,et al. A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo , 2003, Journal of Virology.
[3] A. Aderem,et al. Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.
[4] G Janossy,et al. The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections. , 1999, Seminars in immunology.
[5] Libin Rong,et al. Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips. , 2009, Mathematical biosciences.
[6] S. Twu,et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. , 2006, QJM : monthly journal of the Association of Physicians.
[7] J. French,et al. Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice , 2011, Neurotherapeutics.
[8] F. Lafeber,et al. Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. , 2012, Current pharmaceutical design.
[9] A. Jadhav,et al. A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3‐Cyanopropanoic Acid Moiety , 2010, ChemMedChem.
[10] Steven G. Deeks,et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans , 1999, Nature Medicine.
[11] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[12] R. Koup,et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. , 2003, Immunity.
[13] Eric J Kunkel,et al. Chemokines and the tissue-specific migration of lymphocytes. , 2002, Immunity.
[14] N. Ford,et al. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda , 2011, Annals of Internal Medicine.
[15] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[16] C. Struchiner,et al. Viral Load and CD4 Count Dynamics After HIV-1 Seroconversion in Homosexual and Bisexual Men in Rio de Janeiro, Brazil , 2006, Journal of acquired immune deficiency syndromes.
[17] Alan S. Perelson,et al. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques , 2007, Proceedings of the National Academy of Sciences.
[18] H. Ullum,et al. Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy , 2013, PloS one.
[19] Steve Kaye,et al. Short-course antiretroviral therapy in primary HIV infection. , 2013, The New England journal of medicine.
[20] L M Wahl,et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.
[21] L. Rong,et al. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy. , 2014, Journal of theoretical biology.
[22] D. Mooney,et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks , 2012, Nature Immunology.
[23] L. Picker,et al. CD4+ T‐cell depletion in HIV infection: mechanisms of immunological failure , 2013, Immunological reviews.
[24] Rachael Hughes,et al. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies , 2008, AIDS.
[25] D. Weiner,et al. Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials , 2009, Nature Reviews Immunology.
[26] William J. Kaiser,et al. Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts , 2005, Journal of Virology.
[27] K. Beaumont,et al. IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients , 2005, The Journal of Immunology.
[28] A. Perelson,et al. Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.
[29] Xin Geng,et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.
[30] A. Fauci,et al. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. , 1991, Annals of the New York Academy of Sciences.
[31] M. Harding,et al. ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs , 2001, Expert opinion on investigational drugs.
[32] L. Moulton,et al. Behavioral Impact, Acceptability, and HIV Incidence Among Homosexual Men With Access to Postexposure Chemoprophylaxis for HIV , 2004, Journal of acquired immune deficiency syndromes.
[33] A. Haase,et al. Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. , 2012, Blood.
[34] M. Schechter,et al. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] Alan S Perelson,et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.
[36] Alan S. Perelson,et al. Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy , 2009, PLoS Comput. Biol..
[37] R. Hengel,et al. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans. , 1999, Journal of immunology.
[38] A. Vezzani,et al. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. , 2010, Current opinion in investigational drugs.
[40] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[41] Evan Wood,et al. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia , 2006, AIDS.
[42] J. Petravic,et al. Limited CD4+ T cell proliferation leads to preservation of CD4+ T cell counts in SIV-infected sooty mangabeys , 2010, Proceedings of the Royal Society B: Biological Sciences.
[43] Ross J. Harris,et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.
[44] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[45] C. Sabin,et al. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV‐1 diagnosis , 1992, Clinical and experimental immunology.
[46] Richard H Middleton,et al. Modeling the three stages in HIV infection. , 2013, Journal of theoretical biology.
[47] J. Bijlsma,et al. Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation , 2012, Arthritis Research & Therapy.
[48] G. Pantaleo,et al. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[50] T. Sakaeda,et al. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. , 2004, Current topics in medicinal chemistry.
[51] A S Perelson,et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.
[52] Martin Meier-Schellersheim,et al. CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load1 , 2002, The Journal of Immunology.
[53] J. Schiffer,et al. The Majority of CD4+ T-Cell Depletion during Acute Simian-Human Immunodeficiency Virus SHIV89.6P Infection Occurs in Uninfected Cells , 2014, Journal of Virology.
[54] F. Sallusto,et al. Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T Cells , 2001, The Journal of experimental medicine.
[55] Mark Coles,et al. IL-7-producing stromal cells are critical for lymph node remodeling. , 2012, Blood.
[56] Time Scales of CD4+ T Cell Depletion in HIV Infection , 2007, PLoS medicine.
[57] Alan S. Perelson,et al. Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy , 2001, The Journal of experimental medicine.
[58] Z. Grossman,et al. The Journal of Experimental Medicine , 2000 .
[59] D. Kirschner,et al. Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. , 2000, Journal of acquired immune deficiency syndromes.
[60] D. Hazuda,et al. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. , 1988, The Journal of biological chemistry.
[61] Alan S. Perelson,et al. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[62] Libin Rong,et al. Modeling HIV persistence, the latent reservoir, and viral blips. , 2009, Journal of theoretical biology.
[63] Wolfgang Löscher,et al. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.
[64] V. Quagliarello. The Acquired Immunodeficiency Syndrome: current status. , 1982, The Yale journal of biology and medicine.
[65] Rustom Antia,et al. Understanding the Slow Depletion of Memory CD4+ T Cells in HIV Infection , 2007, PLoS medicine.
[66] H. Masur,et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. , 1981, The New England journal of medicine.
[67] A. Haase,et al. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.
[68] Robert Tibshirani,et al. Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .
[69] Joan S. Chmiel,et al. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. , 1989, American journal of epidemiology.
[70] R H Lyles,et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.
[71] J. Tschopp,et al. Caspase-1 Activation of Lipid Metabolic Pathways in Response to Bacterial Pore-Forming Toxins Promotes Cell Survival , 2006, Cell.
[72] R. Gallo,et al. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[73] A. Haase,et al. Lymphoid tissue structure and HIV-1 infection: life or death for T cells. , 2012, Trends in immunology.
[74] J. McCune,et al. The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.
[75] Kholoud Porter,et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy , 2014, AIDS.